| London Stock Exchange: PYC
Physiomics Plc is engaged in the provision of outsourced systems and computational biology services to pharmaceutical companies. It uses systems biology with cutting edge mathematics to develop models that streamline the drug discovery and development process. The company is developing its lead service Virtual Tumour, which is a sophisticated computer model that simulates tumour cell division and the effect of antineoplastic drugs, taking into consideration the differences between proliferative cells and those that are part of the necrotic core. Physiomics was founded by Peter Hoskins and David Fell in May 2001 and is headquartered in Oxford, the United Kingdom.